Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00667186 · ClinicalTrials.gov registry record · NA

HIV Screening in the Emergency Department Setting

A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
NA
Development phase
9,572
Enrollment target

NCT00667186 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 9,572 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00667186, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
NA
Development phase
9,572 participants
Enrollment target

Study Summary

Late diagnosis of HIV infection is believed to be responsible for high rates of HIV transmission. The purpose of this study is to determine whether targeted screening versus routine screening will identify a greater number of HIV infected participants. This study will also compare the costs of the resources used for targeted screening versus routine screening.

Interventions

  • OTHER Targeted Screening
  • OTHER Routine Screening

Trial Details

FieldValue
Enrollment Target 9,572 participants
Start Date 2008-01
Est. Completion 2010-12
Phase NA

What the Registry Record Tells You About NCT00667186

The ClinicalTrials.gov registry entry for NCT00667186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9,572 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Targeted Screening is the first listed.

NCT00667186 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00667186 about?

NCT00667186 is a clinical study titled "HIV Screening in the Emergency Department Setting". Late diagnosis of HIV infection is believed to be responsible for high rates of HIV transmission. The purpose of this study is to determine whether targeted screening versus routine screening will identify a greater number of HIV infected participants. This study will also compare the costs of the r...

What is the current status of trial NCT00667186?

This trial is currently completed. It is a NA study. The enrollment target is 9,572 participants. The study started on 2008-01. Estimated completion is 2010-12.

What interventions are being tested in trial NCT00667186?

The interventions under investigation include: Targeted Screening (OTHER), Routine Screening (OTHER).

Who is sponsoring clinical trial NCT00667186?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.